Septic shock due to visceral leishmaniasis, probably transmitted from blood transfusion

Journal of Infection in Developing Countries

Volumn 3, Issue 6, 2009, Pages 479-483

  Mpaka, Maria A ^a   Daniil, Zoi ^a   Kyriakou, Despina S ^a   Zakynthinos, Epaminondas ^a  

^a University Hospital of Thessaly   (Greece)

Author keywords

Blood products; Clinical findings; Shock; Transmission; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CEFTAZIDIME; HYPERTENSIVE AGENT; NORADRENALIN; TUBERCULOSTATIC AGENT; VANCOMYCIN;

AGED; AMASTIGOTE; ANAMNESIS; ARTICLE; BLEEDING TENDENCY; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; CHILL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE TRANSMISSION; DRUG TREATMENT FAILURE; ECHOGRAPHY; FEMALE; FEVER; GENERAL CONDITION DETERIORATION; HEMODIALYSIS; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; KIDNEY FAILURE; LOW DRUG DOSE; MICROSCOPY; PANCYTOPENIA; PRESSOR RESPONSE; PROMASTIGOTE; SEPSIS; SEPTIC SHOCK; SPLENOMEGALY; STAINING; SWEATING; THROMBOCYTE COUNT; VISCERAL LEISHMANIASIS; WEIGHT REDUCTION;

BACTERIA (MICROORGANISMS);

EID: 73249123909     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.422     Document Type: Article

References (29)

1. Piscopo TV, Azzopardi CM Leishmaniasis (2007) Postgrad Med J 83: 649-657.
2. Herwaldt BL. Leishmaniasis (1999) Lancet 354: 1191-99.
3. Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's (2005) Principles and practice of infectious diseases 6th ed. Elsevier 2428-2442.
4. André R, Brumpt L, Dreyfus B, Passelecq A, Jacob S (1958) Cutaneous leishmaniasis, cutaneous-glandular leishmaniasis and transfusional kala-azar Trop Dis Bull 55: 379-381.
5. Chung H L, Chow K K, Lu JP (1948) The first two cases of transfusion kala-azar Chin Med J 66: 325-326.
6. Cohen C, Corazza F, De Moll P, Brasseur D (1991) Leishmaniasis acquired in Belgium. Lancet 338: 128.
7. Kleinman SH, Bush MP, Schreiber GB, AuBuchon JP (1996) Declining value of alanine aminotransferase in screening blood donors: missed opportunities. Reply Transfus 36: 847-348.
8. Mauny I, Blanchot I, Degeilh B, Dabadie A, Guiguen C, Roussey M (1993) Leishmaniose viscérale chez un nourisson en Bretagne: discussion sur les modes de transmission hors des zones endémiques. Pédiatrie 48: 237-239.
9. Singh S, Chaudhry VP, Wali JP (1996) Transfusiontransmitted kala-azar in India. Transfusion 36: 848-849.
10. Dey A, Singh S (2006) Transfusion transmitted leishmaniasis: A case report and review of the literature. Indian J Med Microbiol 24: 165-170.
11. Morales MA, Chicharro C, Ares M, et al. (2001) Molecular tracking of infections by Leishmania infantum. Trans R Soc Trop Med Hyg 95: 104-107.
12. Luz KG, DaSilva VO, Gomes EM, Machado FCS, Araujo MAF, Fonseca HEM, et al (1997) Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patients. Am J Trop Med Hyg 57: 168-171.
13. Scarlata F, Vitale F, Saporito L, Reale S, Vecchi VL, Giordano S, Infurnari L, Occhipinti F, Titone L (2008) Asymptomatic Leishmania infantum/chagasi infection in blood donors of western Sicily. Trans R Soc Trop Med Hyg 102: 394-6.
14. Manson-Bahr PEC, Apted FIC (1982) Leishmaniasis. In: Manson-Bahr PEC, Apted FIC, eds. Manson's tropical diseases.18th ed. London: Bailliere Tindall, 93-115.
15. Stone HH, Tool CD, Pugsley WS (1952) Kala-azar (visceral leishmanisis): report of a case with 34 month incubation period and positive Doan-Wright test. Ann Intern Med 36: 686-93.
16. Pearson RD, de Queiroz Sousa A (1995) Clinical spectrum of leishmaniasis. Clin Infect Dis 22: 1-13.
17. Riera C, Fisa R, López-Chejade P, Serra T, Girona E, Jiménez M, Muncunill J, Sedeño M, Mascaró M, Udina M, Gállego M, Carrió J, Forteza A, Portús M. (2008) Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain). Transfusion 48: 1383-9.
18. Le Fichoux Y, Quaranta JF, Aufeuvre JP, Lelievre A, Marty P, Suffia I, et al. (1999) Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in Southern France. J Clin Microbiol 37: 1953-57.
19. Reesink HW (2005) European strategies against the parasite transfusion risk. Transfusion Clinique et Biologique 12: 1-4.
20. Grogle M, Daugirda JL, Hoover DL, Magill AJ, Berman JD (1993) Survivability and infectivity of viscerotropic Leishmania Tropica from operation Desert Storm participants in human blood products maintained under blood bank conditions. Am J Trop Med Hyg 49: 308-15.
21. Mathur P, Samantaray JC (2004) The first probable case of platelet transfusion-transmitted visceral leishmaniasis. Transfusion Medicine 14: 319-21.
22. Spellberg B, Edwards JE, Jr (2001) Type 1/type 2 immunity in infectious diseases. Clin Infect Dis 32: 76-102.
23. Zijlstra EE, El-Hassan AM (2001) Visceral leishmaniasis. Trans Roy Soc Trop Med Hyg 95 Suppl 1: S27-58.
24. Herwaldt BL, Berman JD (1992) Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 46: 296-306.
25. Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M (2008). Leishmaniasis among organ transplant recipients. Lancet Infect Dis. 8: 191-9.
26. Sundar S, Jha TK, Thakur CP, et al. (2003) Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study. Clin Infect Dis 37: 800-804.
27. Gradoni L, Gramiccia M, Scalone A (2003) Visceral leishmaniasis treatment, Italy. Emerg Infect Dis [serial online] http://www.cdc.gov/ncidod/ EID/ vol9no12/03-0178.htm.
28. Syriopoulou V, Daikos GL, Theodoridou M, et al. (2003) Two doses of a lipid formulation of amphotericin B for the treatment of Mediterranean visceral leishmaniasis. Clin Infect Dis 36: 560-566.
29. Kyriakou DS, Alexandrakis MG, Passam FH, Kourelis TV, Foundouli P, Matalliotakis E, et al. (2003) Quick detection of Leishmania in peripheral blood by flow cytometry. Is prestorage leucodepletion necessary for leismaniasis prevention in endemic areas? Transfus Med 13: 59-62.